Literature DB >> 11107049

Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.

M Yamasaki1, Y Takeshima, S Fujii, S Kitaguchi, M Matsuura, K Tagawa, K Inai.   

Abstract

Bronchiolo-alveolar carcinoma (BAC) is a type of lung adenocarcinoma characterized by growth along the alveolar wall. It is divided into two subtypes: sclerosing BAC (SBAC), which has central fibrosis, and non-sclerosing BAC (NSBAC), which lacks central fibrosis. We compared the genetic alterations in these two types of BAC with those in atypical adenomatous hyperplasia (AAH). There were 39 cases of SBAC, 19 of NSBAC and 20 of AAH. To detect the loss of heterozygosity (LOH) we used the microsatellite markers D3S1234 and D3S1300 on chromosome 3p, IFNA and D9S144 on 9p, and TP53 on 17p. We also used polymerase chain reaction-SSCP analysis and direct sequencing to examine a point mutation of the p53 gene at exons 5-8. At the TP53 locus, the frequencies of LOH showed a statistical rank-difference correlation among AAH, NSBAC and SBAC. On chromosomes 3p and 9p there were no statistical differences of LOH among AAH, NSBAC and SBAC. We detected a significant statistical rank-difference correlation in the p53 mutation among AAH, NSBAC and SBAC. These findings suggest that a process of multistep carcinogenesis from AAH through NSBAC to SBAC might occur in some cases of adenocarcinoma, and LOH of 3p and 9p might be an early event of carcinogenesis, while the p53 mutation might be a later event.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11107049     DOI: 10.1046/j.1440-1827.2000.01123.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Bronchiolar columnar cell dysplasia--genetic analysis of a novel preneoplastic lesion of peripheral lung.

Authors:  Reinhard Ullmann; Massimo Bongiovanni; Iris Halbwedl; Susanna Petzmann; Margit Gogg-Kammerer; Anna Sapino; Mauro Papotti; Gianni Bussolati; Helmut H Popper
Journal:  Virchows Arch       Date:  2003-04-09       Impact factor: 4.064

Review 2.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

Review 3.  Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Authors:  Jody C Chuang; Joseph B Shrager; Heather A Wakelee; Joel W Neal
Journal:  Clin Ther       Date:  2016-06-29       Impact factor: 3.393

4.  Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.

Authors:  Ludmila Prudkin; Carmen Behrens; Diane D Liu; Xian Zhou; Natalie C Ozburn; B Nebiyou Bekele; John D Minna; Cesar Moran; Jack A Roth; Lin Ji; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

Review 5.  Preneoplastic lesions of the lung.

Authors:  Alissa K Greenberg; Herman Yee; William N Rom
Journal:  Respir Res       Date:  2002-04-04

6.  Chronic lung injury by constitutive expression of activation-induced cytidine deaminase leads to focal mucous cell metaplasia and cancer.

Authors:  Jiro Kitamura; Munehiro Uemura; Mafumi Kurozumi; Makoto Sonobe; Toshiaki Manabe; Hiroshi Hiai; Hiroshi Date; Kazuo Kinoshita
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

Authors:  Daniela Bettio; Anna Venci; Valentina Achille; Marco Alloisio; Armando Santoro
Journal:  Exp Ther Med       Date:  2015-11-16       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.